Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare to Acquire Applied Precision

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GE Healthcare has inked an agreement to acquire cellular imaging products firm Applied Precision for an undisclosed sum.

Applied Precision's products, which include high-resolution and super-resolution microscopy instruments, are expected to complement GE Healthcare's In Cell analyzers that are used for high-throughput sub-cellular analysis in cell biology research.

GE Healthcare said that it will retain Applied Precision's facility in Issaquah, Wash.

"The worldwide resources of GE Healthcare will allow us to significantly widen our reach into new markets and provide a stronger support network for our existing customers," Applied Precision CEO Joe Victor said in a statement.

The firms expect to close the deal in the second quarter of this year.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.